Skip to search formSkip to main contentSkip to account menu

Oncology drugs

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Approved oncology drugs lack in vivo activity against Trichuris muris despite in vitro activity
Infections with soil-transmitted helminths (STHs) are considered among the most persistent global health problems. The few… 
2016
2016
Approved oncology drugs lack in vivo activity against Trichuris muris despite in vitro activity
Infections with soil-transmitted helminths (STHs) are considered among the most persistent global health problems. The few… 
2016
2016
Factors associated with prescribing restriction on oncology formulary drugs in Malaysia
Background Drugs listed on formularies are often subjected to a variety of utilization restriction measures. However, the degree… 
2015
2015
Acceptance of surrogate end points in clinical trials supporting approval of drugs for cancer treatment by the Japanese regulatory agency.
BACKGROUND This study investigated the historic use of different end points to support approval of drugs for cancer treatment in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)